Deciphering the significance of p53 mutant proteins
Authors:
Open Access
- 2 July 2024
- journal article
- review article
- Published by Elsevier in Trends in Cell Biology
- Vol. 35 (3) , 258-268
Abstract
No abstract availableKeywords
Funding Information
- DFG (TRR353/1)
- DFG (2023-2027)
- Carl-Zeiss-Stiftung (2022-2027)
- Carl-Zeiss-Stiftung (1 5972218)
This publication has 60 references indexed in Scilit:
- p53 mutations define the chromatin landscape to confer drug tolerance in pancreatic cancerMolecular Oncology, 2021
- Mutant p53 suppresses innate immune signaling to promote tumorigenesisCancer Cell, 2021
- Therapeutic Ablation of Gain-of-Function Mutant p53 in Colorectal Cancer Inhibits Stat3-Mediated Tumor Growth and InvasionCancer Cell, 2018
- Mutant p53 Prolongs NF-κB Activation and Promotes Chronic Inflammation and Inflammation-Associated Colorectal CancerCancer Cell, 2013
- Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate PathwayCell, 2012
- Mapping Cancer OriginsCell, 2011
- Mutant p53 Drives Invasion by Promoting Integrin RecyclingCell, 2009
- A Mutant-p53/Smad Complex Opposes p63 to Empower TGFβ-Induced MetastasisCell, 2009
- Gain of Function of a p53 Hot Spot Mutation in a Mouse Model of Li-Fraumeni SyndromeCell, 2004
- Mutant p53 Gain of Function in Two Mouse Models of Li-Fraumeni SyndromeCell, 2004